These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 35365882)
1. Cardioprotective actions of nitroxyl donor Angeli's salt are preserved in the diabetic heart and vasculature in the face of nitric oxide resistance. Velagic A; Li JC; Qin CX; Li M; Deo M; Marshall SA; Anderson D; Woodman OL; Horowitz JD; Kemp-Harper BK; Ritchie RH Br J Pharmacol; 2022 Aug; 179(16):4117-4135. PubMed ID: 35365882 [TBL] [Abstract][Full Text] [Related]
2. The HNO donor Angeli's salt offers potential haemodynamic advantages over NO or dobutamine in ischaemia-reperfusion injury in the rat heart ex vivo. Chin KY; Michel L; Qin CX; Cao N; Woodman OL; Ritchie RH Pharmacol Res; 2016 Feb; 104():165-75. PubMed ID: 26747404 [TBL] [Abstract][Full Text] [Related]
3. The concomitant coronary vasodilator and positive inotropic actions of the nitroxyl donor Angeli's salt in the intact rat heart: contribution of soluble guanylyl cyclase-dependent and -independent mechanisms. Chin KY; Qin C; Cao N; Kemp-Harper BK; Woodman OL; Ritchie RH Br J Pharmacol; 2014 Apr; 171(7):1722-34. PubMed ID: 24372173 [TBL] [Abstract][Full Text] [Related]
4. The nitroxyl anion (HNO) is a potent dilator of rat coronary vasculature. Favaloro JL; Kemp-Harper BK Cardiovasc Res; 2007 Feb; 73(3):587-96. PubMed ID: 17189622 [TBL] [Abstract][Full Text] [Related]
5. Nitroxyl anion donor, Angeli's salt, does not develop tolerance in rat isolated aortae. Irvine JC; Favaloro JL; Widdop RE; Kemp-Harper BK Hypertension; 2007 Apr; 49(4):885-92. PubMed ID: 17309955 [TBL] [Abstract][Full Text] [Related]
6. Chronic administration of the HNO donor Angeli's salt does not lead to tolerance, cross-tolerance, or endothelial dysfunction: comparison with GTN and DEA/NO. Irvine JC; Kemp-Harper BK; Widdop RE Antioxid Redox Signal; 2011 May; 14(9):1615-24. PubMed ID: 20849324 [TBL] [Abstract][Full Text] [Related]
7. Actions of Angeli's salt, a nitroxyl (HNO) donor, on ion transport across mucosa-submucosa preparations from rat distal colon. Pouokam E; Bell A; Diener M Eur J Pharmacol; 2013 Sep; 715(1-3):133-41. PubMed ID: 23747594 [TBL] [Abstract][Full Text] [Related]
8. Vasoactive actions of nitroxyl (HNO) are preserved in resistance arteries in diabetes. Tare M; Kalidindi RS; Bubb KJ; Parkington HC; Boon WM; Li X; Sobey CG; Drummond GR; Ritchie RH; Kemp-Harper BK Naunyn Schmiedebergs Arch Pharmacol; 2017 Apr; 390(4):397-408. PubMed ID: 28074232 [TBL] [Abstract][Full Text] [Related]
9. Nitroxyl donors retain their depressor effects in hypertension. Irvine JC; Ravi RM; Kemp-Harper BK; Widdop RE Am J Physiol Heart Circ Physiol; 2013 Sep; 305(6):H939-45. PubMed ID: 23851276 [TBL] [Abstract][Full Text] [Related]
10. Formation of nitric oxide from nitroxyl anion: role of quinones and ferricytochrome c. Buyukafsar K; Nelli S; Martin W Br J Pharmacol; 2001 Jan; 132(1):165-72. PubMed ID: 11156574 [TBL] [Abstract][Full Text] [Related]
11. Angeli's salt (Na2N2O3) is a precursor of HNO and NO: a voltammetric study of the reactive intermediates released by Angeli's salt decomposition. Amatore C; Arbault S; Ducrocq C; Hu S; Tapsoba I ChemMedChem; 2007 Jun; 2(6):898-903. PubMed ID: 17436261 [TBL] [Abstract][Full Text] [Related]
12. Effects of agents that inactivate free radical NO (NO*) on nitroxyl anion-mediated relaxations, and on the detection of NO* released from the nitroxyl anion donor Angeli's salt. Ellis A; Lu H; Li CG; Rand MJ Br J Pharmacol; 2001 Oct; 134(3):521-8. PubMed ID: 11588105 [TBL] [Abstract][Full Text] [Related]
13. NO- activates soluble guanylate cyclase and Kv channels to vasodilate resistance arteries. Irvine JC; Favaloro JL; Kemp-Harper BK Hypertension; 2003 Jun; 41(6):1301-7. PubMed ID: 12743008 [TBL] [Abstract][Full Text] [Related]
14. Nitric Oxide Resistance, Induced in the Myocardium by Diabetes, Is Circumvented by the Nitric Oxide Redox Sibling, Nitroxyl. Qin CX; Anthonisz J; Leo CH; Kahlberg N; Velagic A; Li M; Jap E; Woodman OL; Parry LJ; Horowitz JD; Kemp-Harper BK; Ritchie RH Antioxid Redox Signal; 2020 Jan; 32(1):60-77. PubMed ID: 31680536 [No Abstract] [Full Text] [Related]
15. Effect of nitroxyl on the hamster retinal nitridergic pathway. Sáenz DA; Bari SE; Salido E; Chianelli M; Rosenstein RE Neurochem Int; 2007; 51(6-7):424-32. PubMed ID: 17543420 [TBL] [Abstract][Full Text] [Related]
16. Cathepsin B is a differentiation-resistant target for nitroxyl (HNO) in THP-1 monocyte/macrophages. Väänänen AJ; Salmenperä P; Hukkanen M; Rauhala P; Kankuri E Free Radic Biol Med; 2006 Jul; 41(1):120-31. PubMed ID: 16781460 [TBL] [Abstract][Full Text] [Related]
17. Redox variants of NO (NO{middle dot} and HNO) elicit vasorelaxation of resistance arteries via distinct mechanisms. Favaloro JL; Kemp-Harper BK Am J Physiol Heart Circ Physiol; 2009 May; 296(5):H1274-80. PubMed ID: 19252101 [TBL] [Abstract][Full Text] [Related]
18. Nitroxyl (HNO) stimulates soluble guanylyl cyclase to suppress cardiomyocyte hypertrophy and superoxide generation. Lin EQ; Irvine JC; Cao AH; Alexander AE; Love JE; Patel R; McMullen JR; Kaye DM; Kemp-Harper BK; Ritchie RH PLoS One; 2012; 7(4):e34892. PubMed ID: 22506056 [TBL] [Abstract][Full Text] [Related]
19. Hydrogen sulfide interacts with nitric oxide in the heart: possible involvement of nitroxyl. Yong QC; Hu LF; Wang S; Huang D; Bian JS Cardiovasc Res; 2010 Dec; 88(3):482-91. PubMed ID: 20660605 [TBL] [Abstract][Full Text] [Related]
20. Quantitative detection of nitroxyl upon trapping with glutathione and labeling with a specific fluorogenic reagent. Johnson GM; Chozinski TJ; Salmon DJ; Moghaddam AD; Chen HC; Miranda KM Free Radic Biol Med; 2013 Oct; 63():476-84. PubMed ID: 23685286 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]